Viewing Study NCT03903406


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2026-03-05 @ 8:18 AM
Study NCT ID: NCT03903406
Status: UNKNOWN
Last Update Posted: 2019-04-04
First Post: 2019-04-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Quality of Life, Symptoms and Treatment Satisfaction in Adult Patients With Relapsed and/or Refractory Multiple Myeloma, Receiving Ixazomib (Ninlaro®) in Combination With Lenalidomide and Dexamethasone in a Real World Setting: Pilot Study
Sponsor: Multinational Center for Quality of Life Research, Russia
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed and/or Refractory Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None quality of life View